wound dehiscence - Nursing Case Study
Pathophysiology
• Primary mechanism: Collagen synthesis disruption—impaired collagen production or cross-linking weakens the wound matrix, compromising tensile strength and leading to separation of wound edges.
• Secondary mechanism: Increased mechanical stress—excessive tension or movement at the wound site surpasses the reduced tensile strength, promoting dehiscence.
• Key complication: Infection risk—open wounds from dehiscence increase susceptibility to bacterial contamination, potentially leading to local or systemic infections.
Patient Profile
Demographics:
45-year-old female, nurse
History:
• Key past medical history: Type 2 diabetes, hypertension, previous C-section
• Current medications: Metformin, Lisinopril, Metoprolol
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Wound dehiscence following abdominal surgery
• Key symptoms: Redness and swelling around the wound, mild fever, increased drainage with a foul odor
• Vital signs: Temperature 100.8°F, heart rate 98 bpm, blood pressure 142/86 mmHg, respiratory rate 22 breaths per minute
Section 1
New Complications:
As the patient's condition progresses, further complications develop, indicating an exacerbation of the underlying issue. Despite initial treatment measures, the patient begins to exhibit signs of systemic infection. Her fever rises to 101.5°F, and she reports feeling increasingly fatigued and experiencing chills. The area around the wound becomes more erythematous, with purulent drainage that has a stronger foul odor, suggesting bacterial colonization and potential abscess formation. Vital signs reveal a heart rate of 110 bpm and a blood pressure of 136/84 mmHg, indicating a compensatory tachycardia in response to the infection. Respiratory rate remains elevated at 24 breaths per minute, pointing to increased metabolic demands.
Laboratory results show a leukocytosis with a white blood cell count of 15,000/mm³, with a left shift indicating a heightened inflammatory response. C-reactive protein levels are elevated, further confirming the presence of an acute inflammatory process. Blood cultures are pending, but the clinical presentation strongly suggests the development of a wound infection, likely complicated by the patient's diabetes, which impairs immune response and healing.
These findings necessitate a reevaluation of the current management strategy. The primary focus is to address the infection aggressively while supporting the patient's systemic condition. Antimicrobial therapy needs to be initiated, avoiding penicillin due to her allergy, and considering coverage for common pathogens such as Staphylococcus aureus or Streptococcus species. Additionally, optimizing glycemic control is crucial to aid in wound healing and immune function, requiring adjustments to her diabetes management plan. The patient's status and lab results warrant close monitoring to prevent progression to sepsis, guiding further clinical decisions and interventions.
Section 2
New Diagnostic Results:
As the clinical team focuses on addressing the infection and managing the patient's condition, the results of the blood cultures come back, revealing the presence of methicillin-resistant Staphylococcus aureus (MRSA), a challenging pathogen known for its resistance to multiple antibiotics. This finding necessitates a swift adjustment in the antimicrobial strategy, with the initiation of vancomycin therapy to effectively target the MRSA infection. The pharmacology team is consulted to ensure therapeutic drug monitoring of vancomycin levels to avoid toxicity while achieving adequate serum concentrations to combat the infection.
In parallel, a wound culture is performed to obtain a more localized microbial profile, and it confirms the presence of MRSA alongside moderate growth of Pseudomonas aeruginosa. This dual infection complicates the therapeutic approach, prompting the addition of an aminoglycoside such as gentamicin for its synergistic effect with vancomycin and its efficacy against Pseudomonas species. Meanwhile, the patient's renal function is closely monitored, given the potential nephrotoxic effects of both vancomycin and gentamicin, especially in the context of her diabetes.
The inflammatory markers, including C-reactive protein and erythrocyte sedimentation rate, remain elevated, indicating ongoing systemic inflammation. The interprofessional team collaborates to enhance her glycemic control, adjusting her insulin regimen to achieve tighter glucose targets, which is critical for improving immune function and promoting wound healing. The patient is educated on the importance of maintaining her blood sugar levels within the recommended range and monitoring for any signs of worsening infection, reinforcing the need for active participation in her care. As the new treatment plan unfolds, the healthcare team remains vigilant, assessing for any signs of improvement or potential complications, such as renal impairment or progression to sepsis, guiding the next steps in her clinical journey.
Section 3
Change in Patient Status:
As the multidisciplinary team continues to monitor the patient's progress, a noticeable change in her clinical status emerges. Despite the targeted antimicrobial therapy, the patient begins to exhibit signs of increasing hemodynamic instability. Her heart rate rises to 118 beats per minute, and blood pressure drops to 88/58 mmHg, indicating potential progression towards sepsis. The patient also becomes febrile again, with a temperature of 38.8°C (101.8°F), and her respiratory rate increases to 24 breaths per minute, accompanied by a slight decrease in oxygen saturation to 92% on room air. These changes prompt the team to reassess her condition urgently.
Laboratory evaluations reveal a further elevation in white blood cell count to 16,500/mm³, alongside a surge in lactate levels to 3.2 mmol/L, signaling systemic perfusion issues and a heightened inflammatory response. Her renal function tests also show a concerning trend, with serum creatinine rising to 2.1 mg/dL from a baseline of 1.5 mg/dL, underscoring the need for immediate intervention to prevent acute kidney injury. The patient's altered hemodynamic parameters and laboratory values suggest a transition from localized infection to potential septic shock, necessitating a rapid response from the healthcare team.
In light of these developments, the team initiates fluid resuscitation with intravenous crystalloids to stabilize her blood pressure and improve tissue perfusion. Simultaneously, they consider optimizing her antimicrobial regimen to ensure adequate coverage and reassess the necessity of continuing gentamicin, given the potential nephrotoxic risk. The patient's diabetes management is further intensified, with continuous glucose monitoring implemented to avoid hyperglycemic episodes, which could exacerbate her condition. With these measures in place, the healthcare team remains vigilant, closely monitoring her response to the interventions, ready to adjust the treatment plan dynamically based on her evolving clinical status.
Section 4
Response to Interventions:
Following the initiation of fluid resuscitation and adjustments to her treatment regimen, the patient demonstrates a transient stabilization in her vital signs. Her blood pressure temporarily improves to 100/60 mmHg, and her heart rate decreases slightly to 110 beats per minute. However, the initial relief is short-lived as her temperature remains elevated at 38.5°C (101.3°F), and her oxygen saturation continues to hover at 91-92% despite supplemental oxygen. The healthcare team notes that her respiratory effort seems increasingly labored, prompting further assessment.
A repeat chest X-ray is ordered, revealing new bilateral infiltrates, suggestive of possible acute respiratory distress syndrome (ARDS) secondary to the systemic inflammatory response. This finding correlates with her increased respiratory rate and decreased oxygen saturation, underscoring the complexity of her evolving condition. Concurrently, her laboratory results show no significant improvement in renal function, with serum creatinine persisting at 2.1 mg/dL, indicating ongoing renal stress.
The team also observes declining urine output, raising concerns about worsening renal perfusion despite fluid resuscitation. These developments necessitate a comprehensive reassessment of the patient's fluid management strategy, possibly incorporating vasopressor support to maintain adequate blood pressure and organ perfusion. The healthcare team remains poised to adjust her antimicrobial therapy further, consulting infectious disease specialists to ensure optimal coverage and minimize nephrotoxic risks. As they plan the next steps, vigilant monitoring and timely interventions remain crucial to navigate the challenges posed by her deteriorating status.
Section 5
New Complications:
Despite the team's efforts to stabilize the patient, her condition continues to deteriorate, manifesting new complications that demand urgent attention. Her respiratory status worsens significantly, with her oxygen saturation dropping to 88% even on high-flow supplemental oxygen. Arterial blood gas analysis reveals a pH of 7.30, PaCO2 of 50 mmHg, and PaO2 of 55 mmHg, indicating respiratory acidosis and hypoxemia, further supporting the diagnosis of ARDS. Her increased work of breathing and use of accessory muscles necessitate consideration for escalation to mechanical ventilation.
In parallel, the patient's renal function declines further, with serum creatinine rising to 2.5 mg/dL and urine output decreasing to less than 20 mL/hour, consistent with acute kidney injury (AKI). This suggests possible prerenal azotemia due to hypoperfusion, compounded by potential nephrotoxic effects of ongoing medication. The healthcare team initiates low-dose norepinephrine to maintain her mean arterial pressure above 65 mmHg, aiming to improve renal perfusion and prevent further deterioration.
Amid these developments, the patient's surgical site reveals increasing purulent discharge with a foul odor, raising suspicion for a deeper infection or abscess formation. A wound culture is obtained, and broad-spectrum antibiotics are adjusted based on preliminary sensitivity patterns to address possible polymicrobial involvement. The team considers a surgical consultation for potential wound exploration and debridement. As her condition becomes more precarious, the focus shifts to a multi-system management approach, integrating respiratory support, hemodynamic stabilization, and precise antimicrobial therapy to navigate these complex complications effectively.